The funding round was led by SoftBank Vision Fund 2 and co-led by Ally Bridge Group to support international expansion and technological development.
"This latest financing equips CMR with significant funds to accelerate our mission of bringing Versius to hospitals worldwide, whilst providing full flexibility to achieve our goals. This major injection of capital that now values us at $3billion not only reflects the level of interest we have seen in our product, but also the scale of the business, and will enable significant technology developments and global expansion. As the lead investor, SoftBank has a wealth of experience supporting disruptive business models and innovative technologies, and we look forward to leveraging their expertise and extensive ecosystem. I would also like to thank our existing investors for their long-term support."
The financing round was led by Glenview Capital and co-led by Novo Holdings.
"Everybody knows that dialysis care must improve. For this to happen, providers and physicians need products that allow greater flexibility to bring dialysis directly to the patient, while simplifying complexity and reducing the overall cost of care. Our small, simple-to-use, and powerful dialysis system SC+ is positioned to help transform kidney care. The funding we are announcing today will allow us to accelerate our emergence as a significant force in this market."
The company received support in the latest round of the Artificial Intelligence in Health and Care Award.
"The Navenio team is both honoured and delighted to receive the AI in Health and Care Award. The funding will help us accelerate being able to support more teams and patients across the NHS, as we look to build on the positive impact that our technology has provided, particularly during the pandemic. Artificial intelligence is one of many technologies making a real world impact in the healthcare sector, and Navenio is proud to help spearhead digital transformation alongside the other award recipients"
British Design Fund backs London-based Koalaa as the prosthetics maker expands its manufacturing capacity and international reach.
"We’re delighted to have the backing of British Design Fund and look forward to working with them as we scale-up and expand our operations in the UK, but also begin entering new markets across the world."
The seed investment from Mercia and private backers will fund product finalisation and commercial launch.
"I have spent my working life involved in developing products to improve total knee surgery. It is exciting to be part of a small med tech start up with a big vision to deliver accessible innovation to improve patient outcome for total knee patients across the globe."
.png)
